Although a vaccine could be the ultimate solution to curb the COVID-19 pandemic and stop future ones, it will not be 100% effective. If it is anything like the flu vaccine, it will most likely be slightly more than 50% effective.
Oct 2, 2020
0
2
Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic. These minute proteins, also called immunoglobulins, are ...
Sep 16, 2020
0
2
Sophie Lucas (University of Louvain de Duve Institute) and her team have succeeded in neutralizing a molecule that blocks the immune system against cancer. The UCLouvain scientists discovered that this new immunotherapy increases ...
Sep 11, 2020
0
27
University of Toronto researcher Sachdev Sidhu and his collaborators are engineering antibody molecules that can neutralize the novel coronavirus in the body before it invades cells.
Apr 1, 2020
0
17
With much of society now effectively in lockdown, how will we know when it's safe to resume something like normality?
Mar 31, 2020
0
10
An international research team has been able to describe the overall structure of the antibody type IgE, which is the key molecule in allergic diseases. This is a scientific breakthrough which provides important insights ...
Feb 24, 2020
0
1
A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies. The identification can be done through ...
Aug 1, 2019
0
1
Contrary to prior belief, white blood cells enter the spleen primarily via vessels in the red pulp. The research results contradict ideas regarding how the spleen produces antibodies vital for the human body.
Apr 3, 2019
0
5
In late July there were reports in the media from a conference in Chicago about Alzheimer's disease. The focus of journalists' attention was a new study of how the progression of the disease is affected by the BAN2401 antibody, ...
Oct 19, 2018
0
3
Wistar scientists and collaborators demonstrate for the first time that through engineering constructs, they can express DNA-encoded monoclonal antibodies (DMAbs) targeting CTLA-4, an important cancer checkpoint molecule ...
Oct 4, 2018
0
33
